Moderna, Inc. (MRNA)

Last Closing Price: 106.56 (2024-03-28)

Free Cash Flow (Quarterly)

Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)

Moderna, Inc. (MRNA) had Free Cash Flow of $-3.83B for the most recently reported fiscal quarter, ending 2023-12-31.

Figures for fiscal quarter ending 2023-12-31
Income Statement Financials
$2.81B
$217.00M
$929.00M
$1.88B
$2.81B
$6.00M
$64.00M
$70.00M
$70.00M
$217.00M
$217.00M
$217.00M
$217.00M
$6.00M
$188.00M
382.00M
382.00M
$0.62
$0.63
Balance Sheet Financials
$10.32B
$1.95B
$8.10B
$18.43B
$3.02B
$575.00M
$1.56B
$4.57B
$13.85B
$13.85B
$13.85B
382.00M
Cash Flow Statement Financials
$-3.12B
$4.21B
$-1.38B
$3.22B
$2.93B
$-289.00M
$305.00M
--
--
Fundamental Metrics & Ratios
3.42
--
--
0.04
0.04
66.95%
0.21%
0.21%
--
2.49%
7.72%
Free Cash Flow
$-3.83B
--
--
--
0.15
4.60
3.15
28.56
1.57%
1.57%
1.18%
1.50%
$36.27
$-10.01
$-8.16